Science
Mechanism of Action
Escin exerts its effects by primarily reducing vascular permeability and improving microcirculation, which effectively inhibits edema formation and strengthens capillary integrity. Its anti-inflammatory actions involve inhibiting the release of inflammatory mediators like high mobility group protein B1 (HMGB1) from macrophages, decreasing pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6, and suppressing NF-κB activation. Furthermore, escin exhibits antioxidant properties by increasing the activity of enzymes like myeloperoxidase, superoxide dismutase, and glutathione peroxidase. It also demonstrates glucocorticoid-like activity through modulation of glucocorticoid receptors (GR) and inhibition of PGE2 production, while enhancing the integrity of blood vessel walls by reducing the catabolism of tissue mucopolysaccharides.
Research
Clinical Evidence
High confidence1-2%
Key findings
- 01 Topical gel formulations containing 1% or 2% escin have demonstrated robust efficacy in treating localized edema, blunt lesions, hematoma, superficial thrombophlebitis, and painful vertebral syndrome, with excellent or good tolerability in human trials.
- 02 A 1% escin phytosome, when combined with other ingredients, significantly improved peripheral skin microcirculation parameters and aided in preventing skin lesions and ulcers in individuals with diabetic foot.
- 03 In preclinical models, β-escin at 60 µg/mL (approx. 0.006%) significantly reduced blood vessel branch point formation, suggesting anti-angiogenic effects without cytotoxicity.
- 04 In vitro studies showed escin concentrations of 100-750 ng/mL partially protected human umbilical vein endothelial cells (HUVECs) against ATP loss and inhibited hypoxia-induced increases in phospholipase A2 (PLA2) activity by 57–72%, while also preventing increased adhesiveness for neutrophils.
- 05 Overall, escin in topical formulations has been shown to reduce inflammation and swelling following trauma or surgery, improve microcirculation, and decrease capillary permeability.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
β-aescin's water solubility is significantly enhanced above its pKa of 4.7 ± 0.2 due to deprotonation. It is also soluble in alcohols such as methanol and ethanol, with amorphous forms being easily water-soluble. Escin phytosome formulations are dispersible in water and glycerin, exhibiting stability up to 80°C, though incorporation below 40°C is recommended for optimal integration.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has not published a specific safety assessment for Escin. While β-escin sodium has received FDA approval for pharmaceutical clinical usage (not cosmetic), the FDA does not mandate pre-market approval for cosmetic ingredients. EWG Skin Deep rates Escin with low concern for cancer, allergies & immunotoxicity, developmental and reproductive toxicity, and usage restrictions.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Escin is a highly valuable ingredient for precision skincare, offering clinically supported benefits in improving microcirculation, reducing inflammation and swelling, and strengthening capillary integrity across all skin types with low irritancy and comedogenicity.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources